Patient and system delays in the treatment of acute coronary syndrome

Marta Viana1, Olga Laszczyńska1, Carla Araújo2

  • 1EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.

Insights

Many ST-segment elevation myocardial infarction (STEMI) and high-risk non-ST-elevation acute coronary syndrome (NSTE-ACS) patients experience delays in treatment. Patient and system factors contribute to a failure to achieve timely reperfusion, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Acute Coronary Syndromes
  • Health Services Research

Background:

  • European Society of Cardiology guidelines recommend early reperfusion for STEMI and timely invasive strategies for high-risk NSTE-ACS.
  • Significant patient and system delays can impede timely treatment for acute coronary syndromes.
  • Understanding predictors of delay is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess patient and system delays in STEMI and NSTE-ACS patients.
  • To identify factors contributing to prolonged delays based on diagnosis and risk profile.
  • To evaluate the proportion of patients receiving timely reperfusion.

Main Methods:

  • A cohort of 939 patients admitted to two Portuguese hospitals between August 2013 and December 2014 was analyzed.
  • Patient demographics, symptom onset, first medical contact, and treatment timelines were recorded.
  • Statistical analysis was used to identify predictors of delay.

Main Results:

  • A high percentage of patients, particularly high-risk NSTE-ACS (57.7%) and intermediate-risk NSTE-ACS (52.1%), experienced delays from symptom onset to first medical contact (≥120 min).
  • STEMI patients also faced delays (43.3%).
  • Patient-related factors (self-transport, misinterpretation of symptoms) and system-related factors (non-PCI hospital admission, weekend admission, complications) were associated with prolonged delays. 78.0% of STEMI and 65.8% of high-risk NSTE-ACS patients exceeded recommended treatment times.

Conclusions:

  • Both patient-related and system-related delays prevent a significant number of STEMI and high-risk NSTE-ACS patients from receiving timely reperfusion.
  • Interventions targeting patient education and healthcare system efficiency are needed to improve treatment access.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
143
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
564
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
198
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
289
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
173